Septerna, Inc.

Healthcare

NASDAQ:SEPN · NASDAQ Global Select

Market Cap $1.63B Beta 2.38 P/E (TTM) -43.6

$36.17 -2.04%

-$0.73 today

52W Low $9.96High $37.32

Vol 0.27M · Avg 0.32M

EPS (TTM) -$0.81Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+243.49%

Period High

$36.17

Period Low

$10.51

Latest

$36.17

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Tango Therapeutics, Inc.

NASDAQ:TNGX

$3.58B

Nurix Therapeutics, Inc.

NASDAQ:NRIX

$1.49B

Fortrea Holdings Inc.

NASDAQ:FTRE

$1.44B

Bicara Therapeutics Inc. Common Stock

NASDAQ:BCAX

$1.24B

EyePoint Pharmaceuticals, Inc.

NASDAQ:EYPT

$1.13B

Arbutus Biopharma Corporation

NASDAQ:ABUS

$883.98M

Kura Oncology, Inc.

NASDAQ:KURA

$852.77M

Maravai LifeSciences Holdings, Inc.

NASDAQ:MRVI

$735.64M

Prime Medicine, Inc.

NASDAQ:PRME

$564.43M

ProKidney Corp.

NASDAQ:PROK

$263.74M

What is the latest SEPN filing?

The latest filing shown is 4 dated Jun 16, 2026.

How many recent filings does SEPN have?

Intrinsic Alpha currently shows 20 recent filings for SEPN.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.